Abivax S.A. logo

Abivax S.A.

ABVX | NASDAQ
Chart Builder DCF Calculator
$105.04
-$1.95 (-1.82%)
At close: Sep 18, 2026, 4:00 PM ET
$106.16
+$1.12 (+1.07%)
Pre-market: Sep 21, 2026, 8:54 AM ET

Market Data

Market Cap
$7.71B
Enterprise Value
$6.1B
Beta
-0.25
Average Volume
1.71M
Shares Outstanding (Diluted)
69.53M
Shares Change YoY
43.98%
Institutional Ownership
71.97%
Exchange
NASDAQ
ISIN
US00370M1036

Price Performance

Price Change 1M
-12.9%
Price Change 3M
3.3%
Price Change 6M
-9.0%
Price Change YTD
-21.5%
Price Change 1Y
26.1%
Price Change 3Y
1165.5%
Price Change 5Y
1165.5%
1M CAGR (ann.)
-19.2%
1Y CAGR (ann.)
29.7%
5Y CAGR (ann.)
N/A
All-Time CAGR
138.8%

Valuation

PE Ratio
-25.11
Forward PE
N/A
PEG Ratio
0.31
Forward PEG
3.80
PS Ratio
N/A
Forward PS
66.50
PB Ratio
14.43
P/FCF Ratio
-65.02
P/Adj. FCF Ratio
-68.07
P/OCF Ratio
-39.76
EV/Sales
N/A
EV/EBIT
-20.20
EV/EBITDA
-20.27
EV/FCF
-58.26
Earnings Yield
-4.0%
FCF Yield
-1.6%
Adj. FCF Yield
-1.5%

Financial Health

Net Cash
€472.13M
Total Debt
€45.89M
Cash & Short-Term Investments
€530.16M
Total Assets
€652.05M
Current Ratio
8.75
Quick Ratio
8.75
Debt / Equity Ratio
0.10
Debt / EBITDA
-0.15
Debt / FCF
-0.44
OCF / Debt
-2.28
Interest Coverage
-8.79
Altman Z-Score
25.77
Piotroski F-Score
3

Margins & Profitability

Gross Profit Margin
0.0%
Operating Profit Margin
0.0%
EBITDA Margin
0.0%
Net Profit Margin
0.0%
FCF Margin
N/A
Adj. FCF Margin
N/A
SBC / Revenue
0.0%
SBC Impact (per share)
-4.5%

Returns

Return on Assets
-57.5%
Return on Equity
-165.2%
Return on Invested Capital
-45.5%
Return on Capital Employed
-48.1%
Return on Tangible Assets
-60.1%

Historical Growth (CAGR)

Revenue CAGR 3Y
0.0%
Revenue CAGR 5Y
39.2%
Revenue CAGR 10Y
-37.8%
EPS CAGR 3Y
-16.6%
EPS CAGR 5Y
-21.4%
EPS CAGR 10Y
-12.0%
FCF CAGR 3Y
-34.1%
FCF CAGR 5Y
-45.2%
FCF CAGR 10Y
-27.7%

Analyst Forecasts

Analyst Rating
Buy
Analyst Count
13
EPS Growth Next 3Y
77.2%
Revenue Growth Next 3Y
N/A
Earnings Date
Sep 20, 2026
EPS Estimate (next Q)
-$1.13
EPS Growth Est (next Q)
14.2%
Revenue Est (next Q)
$917.32K
Revenue Growth Est (next Q)
-39.8%

Fair Value Estimates

Graham Number
N/A
Graham Upside
N/A
Lynch Fair Value
N/A
Lynch Upside
N/A
Price Target
$153
Price Target Upside
45.7%

Cash Flow

Operating Cash Flow
€-104.62M
Free Cash Flow
€-104.63M
Adj. Free Cash Flow
€-99.95M
FCF Per Share
-$2.33
OCF Per Share
-$2.33
OCF/S Ratio
0.0%

Income Statement

Revenue
€0
Gross Profit
€0
Operating Income
€-246.06M
EBITDA
€-300.7M
Net Income
€-336.1M
EPS (Diluted)
-$3.69
Revenue / Employee
N/A
Profit / Employee
$-4.2M
Employees
80

© 2026 bestshares.com. All rights reserved.